Naltrexone Hydrochloride Accord Healthcare Ireland (Naltrexone Hydrochloride)

The medication acts as a competitive antagonist at μ‑, κ‑, and δ‑opioid receptors. By occupying these receptors without activating them, it blocks both naturally occurring opioids and external opioid drugs, diminishing their reinforcing and euphoric effects and helping to curb dependence.

The specific dosage and regimen of Naltrexone Hydrochloride are determined by the prescribing clinician based on the patient’s medical condition, treatment goals, and response. Healthcare professionals tailor the dose to each individual’s needs.

Safety data for Naltrexone Hydrochloride in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefits justify any possible risks to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with opioid agonist therapies such as methadone or buprenorphine, Naltrexone Hydrochloride is an antagonist that does not produce opioid effects. It is useful for patients who prefer a non‑opioid option and have completed detoxification, but it requires strict adherence to avoid precipitated withdrawal.

Naltrexone Hydrochloride tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture and direct sunlight to maintain its stability and potency.

The medication is taken orally, typically as a tablet, with or without food as directed by a healthcare professional. Patients should follow the prescriber’s instructions regarding timing and any required fasting periods.

Serious risks include hepatotoxicity, severe depression, suicidal thoughts, and allergic reactions such as anaphylaxis. Patients should be monitored regularly for liver function and mood changes, and any signs of an allergic response require immediate medical attention.

Individuals who are currently dependent on opioids, have acute hepatitis or severe liver impairment, or have a known hypersensitivity to naltrexone or any excipients should avoid using this medication. It is also contraindicated in patients who have not completed opioid detoxification.